UBS Group AG - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 93 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,966
+426.4%
43,512
+1737.5%
0.00%
Q4 2022$2,463
-69.2%
2,368
-64.4%
0.00%
Q3 2022$8,000
+300.0%
6,645
+561.9%
0.00%
Q2 2022$2,000
-97.0%
1,004
-95.4%
0.00%
Q1 2022$67,000
+1575.0%
21,954
+1797.5%
0.00%
Q2 2021$4,000
-97.3%
1,157
-98.0%
0.00%
Q1 2021$149,000
+0.7%
57,915
-1.9%
0.00%
Q4 2020$148,000
+52.6%
59,028
+25.5%
0.00%
Q3 2020$97,000
-54.9%
47,043
-32.3%
0.00%
Q2 2020$215,000
+24.3%
69,471
-8.7%
0.00%
Q1 2020$173,000
-18.4%
76,060
+29.8%
0.00%
Q4 2019$212,000
+69.6%
58,589
+59.9%
0.00%
Q3 2019$125,000
+108.3%
36,641
+187.0%
0.00%
Q2 2019$60,000
+445.5%
12,765
+297.0%
0.00%
Q1 2019$11,000
-86.2%
3,215
-89.3%
0.00%
Q4 2018$80,000
+14.3%
29,997
+138.4%
0.00%
Q3 2018$70,000
+112.1%
12,581
+93.8%
0.00%
Q2 2018$33,000
+175.0%
6,491
+324.2%
0.00%
Q4 2017$12,000
-47.8%
1,530
-60.9%
0.00%
Q3 2017$23,000
+475.0%
3,915
+149.4%
0.00%
Q1 2017$4,000
-69.2%
1,570
-82.5%
0.00%
Q4 2016$13,000
+333.3%
8,969
+517.7%
0.00%
Q3 2016$3,000
-66.7%
1,452
-64.3%
0.00%
Q4 2015$9,000
-47.1%
4,067
-33.1%
0.00%
Q2 2015$17,0006,0800.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders